Search Results - A. T. Gerds

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    P1062: A REAL-WORLD EVALUATION OF THE ASSOCIATION BETWEEN ELEVATED BLOOD COUNTS AND THROMBOTIC EVENTS IN POLYCYTHEMIA VERA: AN ANALYSIS OF DATA FROM THE REVEAL STUDY by A. T. Gerds, R. Mesa, J. M. Burke, M. R. Grunwald, R. Scherber, J. Yu, J. Hamer-Maansson, S. T. Oh

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  2. 2

    P1060: REAL-WORLD CLINICAL OUTCOMES AFTER 3 AND 6 MONTHS OF TREATMENT WITH FEDRATINIB FOLLOWING RUXOLITINIB FAILURE by J. Mascarenhas, A. T. Gerds, J. K. Kish, P. Abraham, A. Balanean, J. A. Nadal, D. Liassou, B. A. Feinberg, A. McBride, C. Harrison

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  3. 3

    P1057: REAL-WORLD UTILIZATION OF FEDRATINIB FOR MYELOFIBROSIS FOLLOWING RUXOLITINIB FAILURE by C. Harrison, J. Mascarenhas, P. Abraham, J. A. Nadal, A. Balanean, A. McBride, J. K. Kish, D. Liassou, B. A. Feinberg, A. T. Gerds

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  4. 4

    P1033: A PHASE 2 STUDY OF THE LSD1 INHIBITOR IMG-7289 (BOMEDEMSTAT) FOR THE TREATMENT OF ESSENTIAL THROMBOCYTHEMIA (ET) by F. Palandri, D. M. Ross, T. Cochrane, C. Tate, S. W. Lane, S. R. Larsen, A. T. Gerds, A. B. Halpern, J. Shortt, J. M. Rossetti, K. M. Pettit, J. Liang, A. Mead, M. Marchetti, A. Vannucchi, A. Wilson, J. R. Göthert, M. Hanna, A. Jones, J. Peppe, G. Natsoulis, T. McClure, W.-J. Hong, W. S. Stevenson, C. N. Harrison, M. Talpaz, N. Vianelli, H. Y. Rienhoff, Jr.

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


Search Tools: